Dasatinib
Dasatinib

144.5
This medication aids in limiting the proliferation of key cancer-related cells.


Ingredient
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Dasatinib
Reference Brand
Sprycel
Product Origin
Generic Product
Reference Manufacturer
Bristol-Myers Squibb
Product Form
Tablet, Oral Solution
Regulatory Classification
Rx
Primary Category
Oncology Support
Product Category
Tyrosine Kinase Inhibitor
Pharmacological Class
Antineoplastic
Manufacturer Description
Formulated for chronic myeloid leukemia to target cancer cell pathways and support oncology management.
Mechanism of Action
Dasatinib inhibits multiple tyrosine kinases, including Bcr-Abl and the SRC family. By blocking these signaling enzymes, it prevents the proliferation of malignant cells and induces apoptosis in leukemia cell lines.
Route of Administration
Oral
Onset Time
1–3 months
Duration
Ongoing use required
Contraindications
Hypersensitivity to dasatinib, Pregnancy
Severe Adverse Events
Myelosuppression, Pleural effusion, Pulmonary arterial hypertension — requires immediate medical attention
Common Side Effects
Fatigue, Nausea, Headache
Uncommon Side Effects
Diarrhea, Musculoskeletal pain, Rash
Drug Interactions
Alcohol, Grapefruit, Ketoconazole, Rifampin, Proton Pump Inhibitors
Pregnancy Safety Warnings
FDA Category D: High risk of fetal toxicity. Breastfeeding: Not recommended.
Age Restrictions
Safety and efficacy established in pediatric patients one year and older.
Storage Guidelines
Store at room temperature.
Related Products
Gleevec, Tasigna, Bosulif
Information related to Dasatinib is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
How to order Muscle Spasm Medications Ireland - Buy Baclofen UK